DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
Go back to DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer| (NASDAQ: DMAC) | Delayed: 6.39 -0.36 (5.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.75 | 52 Week High | $ | |||
| Open | $6.72 | 52 Week Low | $ | |||
| Day High | $6.74 | P/E | N/A | |||
| Day Low | $6.34 | EPS | $ | |||
| Volume | 116,507 | |||||

